Post Market Study of Parietene™ DS Composite Mesh in Ventral Hernia Repair

A multi-center post-market single arm prospective study of Parietene™ DS Composite Mesh in
subjects undergoing ventral hernia repair to confirm its clinical safety and performance in
the short (1, 3 months), mid (12 months) and long term (24 months)

125 male or female adults subjects will be enrolled in a minimum of 4 USA sites who are
undergoing elective ventral hernia repair (primary or incisional)

Inclusion Criteria:

- Preoperative Inclusion Criteria

1. Subject has provided informed consent

2. Subject is ≥18 years of age (at the time of consent)

3. Subject is undergoing elective ventral hernia repair (primary or incisional) with
intraperitoneal mesh placement

Exclusion Criteria:

- Preoperative Exclusion Criteria

1. BMI > 45 kg/m2

2. Subject is undergoing emergency surgery

3. Subject is pregnant or planning to become pregnant during study participation
period

4. Subject is unable or unwilling to comply with the study requirements or follow-up
schedule

5. Subject has comorbidities which, in the opinion of the Investigator, will not be
appropriate for the study or the subject has an estimated life expectancy of less
than 6 months

6. The subject has participated in another investigational drug or device research
study within 30 days of enrollment

7. Subject has a parastomal hernia

- Intra-operative Exclusion Criteria

1. Subject's hernia repair is in a contaminated or infected site (CDC wound class
2-4) as assessed by the Investigator(s)

2. Subject is undergoing "bridging" repair technique with the mesh placed in an
"inlay" position

3. Surgeon is unable to completely remove existing mesh from prior surgery

4. Surgeon overlays 2 meshes

5. Procedure is a robotically-assisted laparoscopic repair

6. Subject receives any mesh other than Parietene™ DS composite mesh